➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Dow
AstraZeneca
McKesson
Colorcon

Last Updated: May 16, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PRIALT

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Prialt

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00047749 Prialt (Ziconotide) In Severe Chronic Pain Completed Elan Pharmaceuticals Phase 3 2002-08-01 The purpose of this study is to understand the effects of intrathecal ziconotide (an experimental pain medication) when the dose is slowly increased over a 3-week period in patients with severe chronic pain. During the weaning phase, the study will also gather information about switching from other intrathecal or IT medication (slowly pumped directly into the space around the spine) to other systemic pain medication (by mouth or through the skin using a patch). After being weaned off current IT medication, patients will be placed on IT ziconotide or placebo (non-active substance) as well as being allowed a stable dose of systemic pain medications. Patients who complete this study may be eligible for long-term ziconotide therapy via extension protocol ELN92045-352.
NCT00076544 Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain Completed Elan Pharmaceuticals Phase 3 2004-02-01 The purpose of this open-label study is to give chronic severe pain patients with existing intrathecal pump systems access to ziconotide.
NCT01373983 Intrathecal Bolus Doses of Ziconotide Completed University Hospital, Linkoeping Phase 4 2011-08-01 The purpose of this study is to evaluate if the effect of ziconotide can be tested by intrathecal bolus doses.
NCT01888120 Patient Registry of Intrathecal Ziconotide Management(PRIZM) Active, not recruiting Jazz Pharmaceuticals N/A 2013-07-01 The objectives of this study are to evaluate the effectiveness, long-term safety, tolerability, satisfaction with treatment, and health-related quality of life (HRQoL) associated with Intrathecal PRIALT use for severe chronic pain of varying etiologies.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Prialt

Condition Name

Condition Name for Prialt
Intervention Trials
Pain 2
Painful Myelopathy 1
Neuropathic Pain Secondary to a Clear Etiology 1
Peripheral Neuropathy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Prialt
Intervention Trials
Chronic Pain 2
Peripheral Nervous System Diseases 1
Neuralgia 1
Spinal Cord Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Prialt

Trials by Country

Trials by Country for Prialt
Location Trials
United States 82
Sweden 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Prialt
Location Trials
Ohio 4
New York 4
Georgia 3
Florida 3
Kentucky 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Prialt

Clinical Trial Phase

Clinical Trial Phase for Prialt
Clinical Trial Phase Trials
Phase 4 3
Phase 3 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Prialt
Clinical Trial Phase Trials
Completed 3
Unknown status 1
Active, not recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Prialt

Sponsor Name

Sponsor Name for Prialt
Sponsor Trials
Elan Pharmaceuticals 2
University Hospital, Linkoeping 1
Albany Medical College 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Prialt
Sponsor Trials
Industry 3
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Express Scripts
Moodys
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.